Control of microglial neurotoxicity by the fractalkine receptor
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Microglia, the resident inflammatory cells of the CNS, are the only CNS cells that express the fractalkine receptor (CX3CR1). Using three different in vivo models, we show that CX3CR1 deficiency dysregulates microglial responses, resulting in neurotoxicity. Following peripheral lipopolysaccharide injections, Cx3cr1-/- mice showed cell-autonomous microglial neurotoxicity. In a toxic model of Parkinson disease and a transgenic model of amyotrophic lateral sclerosis, Cx3cr1-/- mice showed more extensive neuronal cell loss than Cx3cr1+ littermate controls. Augmenting CX3CR1 signaling may protect against microglial neurotoxicity, whereas CNS penetration by pharmaceutical CX3CR1 antagonists could increase neuronal vulnerability.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Microglia were labeled using the CX3CR1+/GFP mouse line in which all microglia express EGFP under the control of fractalkine receptor, CX3CR1, expression (Figure 1, S1, and S5) (Cardona et al., 2006; Jung et al., 2000; Saederup et al., 2010).”
From Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner (2012) · cites this paper as Cardona et al., 2006
In the citing paper
“microglia are uniformly CX3CR1+ from early embryonic time points through adulthood (Cardona et al., 2006; Ginhoux et al., 2010; Schulz et al., 2012)”
From Differential roles of microglia and monocytes in the inflamed central nervous system (2014) · cites this paper as Cardona et al., 2006
In the citing paper
“Conflicting evidence in the literature suggests either neurotoxic or neuroprotective effects of CX3CR1 deletion in various disease models (Cardona et al., 2006; Fuhrmann et al., 2010).”
From CX3CR1 in Microglia Regulates Brain Amyloid Deposition through Selective Protofibrillar Amyloid-β Phagocytosis (2010) · cites this paper as Cardona et al., 2006
In the citing paper
“Our findings support the concept that fractalkine through its receptor CX3CR1 (Harrison et al., 1998) acts as a repressor of microglia activation (Cardona et al., 2006).”
From CX3CR1 in Microglia Regulates Brain Amyloid Deposition through Selective Protofibrillar Amyloid-β Phagocytosis (2010) · cites this paper as Cardona et al., 2006
In the citing paper
“While CX3CR1 is expressed by many leukocyte cell types in the periphery, 15 in the brain CX3CR1 is exclusively expressed by microglia 13 whereas CX3CL1 is highly expressed within neurons.14”
From CX3CR1 Deficiency Alters Microglial Activation and Reduces Beta-Amyloid Deposition in Two Alzheimer's Disease Mouse Models (2010) · cites this paper as [13]
15 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo
Nimmerjahn, A., Kirchhoff, F., & Helmchen, F. (2005) · Science · doi:10.1126/science.1110647 · Cited by 5,827 · cited 1×
“Microglia, which have characteristics of immature myeloid cells, sample the extracellular space of the healthy CNS through continuous extension, retraction and remodeling of cellular processe”
BackgroundMicroglia: a sensor for pathological events in the CNS
Kreutzberg, G. W. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)10049-7 · Cited by 4,396 · cited 1×
“In response to injury, microglial cells undergo rapid morphological and functional activation and acquire properties of mature myeloid cells, including antigen presentation, reactive species generation, matrix metalloproteinase (MMP) expression and phagocytosis, as well as cytokine and growth factor secretio”
BackgroundATP mediates rapid microglial response to local brain injury in vivo
Davalos, D., Grutzendler, J., Yang, G., Kim, J. V., Zuo, Y., Jung, S., Littman, D. R., Dustin, M. L., & Gan, W.-B. (2005) · Nature Neuroscience · doi:10.1038/nn1472 · Cited by 3,913 · cited 1×
“Microglia, which have characteristics of immature myeloid cells, sample the extracellular space of the healthy CNS through continuous extension, retraction and remodeling of cellular processe”
BackgroundSelf-citationBlood Monocytes Consist of Two Principal Subsets with Distinct Migratory Properties
Geissmann, F., Jung, S., & Littman, D. R. (2003) · Immunity · doi:10.1016/s1074-7613(03)00174-2 · Cited by 3,391 · cited 1×
“However, peripheral immune and inflammatory reactions are mostly unaltered in Cx3cr1 −/− or Cx3cl1 −/− mic”
BackgroundSelf-citationJung, S., Aliberti, J., Graemmel, P., Sunshine, M. J., Kreutzberg, G. W., Sher, A., & Littman, D. R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.11.4106-4114.2000 · Cited by 2,632
Self-citationThe many roles of chemokines and chemokine receptors in inflammation
Charo, I. F., & Ransohoff, R. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052723 · Cited by 2,523 · cited 1×
“Based on these and other findings, efforts to develop pharmacological inhibitors of CX3CR1 are in progres”
BackgroundSelf-citationCX 3 CR1-Mediated Dendritic Cell Access to the Intestinal Lumen and Bacterial Clearance
Niess, J. H., Brand, S., Gu, X., Landsman, L., Jung, S., McCormick, B. A., Vyas, J. M., Boes, M., Ploegh, H. L., Fox, J. G., et al. (2005) · Science · doi:10.1126/science.1102901 · Cited by 1,611 · cited 2×
“Targeted deletion of CX(3)CR1 reveals a role for fractalkine in cardiac allograft rejection.”
BackgroundSelf-citationMicroglia-specific localisation of a novel calcium binding protein, Iba1
Ito, D., Imai, Y., Ohsawa, K., Nakajima, K., Fukuuchi, Y., & Kohsaka, S. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00040-0 · Cited by 1,476 · cited 1×
“Results Neuronal damage in Cx3cr1 −/− mice after systemic LPS We first examined the GFP + population in the CNS of Cx3cr1 GFP mice and found that green fluorescent cells overlapped precisely with brain cells expressing microglial markers such as ionized calcium-binding adapter molecule-1 (IBA-1”
BackgroundHarrison, J. K., Jiang, Y., Chen, S., Xia, Y., Maciejewski, D., McNamara, R. K., Streit, W. J., Salafranca, M. N., Adhikari, S., Thompson, D. A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.18.10896 · Cited by 1,176 · cited 1×
“dtd" [ ]> CX3CR1 is expressed by monocytes, dendritic cells (DCs), and subsets of T cells and natural killer cells in the circulation and by microglia in the central nervous system (CNS”
Takahashi, K., Rochford, C. D. P., & Neumann, H. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041611 · Cited by 1,124 · cited 1×
“Knockdown of TREM2 in mouse microglia impairs their phagocytic activity and enhances inflammatory gene expression, suggesting a mechanism for the human disorde”
BackgroundDown-Regulation of the Macrophage Lineage Through Interaction with OX2 (CD200)
Hoek, R. M., Ruuls, S. R., Murphy, C. A., Wright, G. J., Goddard, R., Zurawski, S. M., Blom, B., Homola, M. E., Streit, W. J., Brown, M. H., et al. (2000) · Science · doi:10.1126/science.290.5497.1768 · Cited by 1,022 · cited 1×
“Mice deficient for CD200, a neuronal glycoprotein whose receptor, CD200R, is expressed by all myeloid cells, show aberrant microglial physiology including morphological activation of microglia in the resting CNS and accelerated response to facial nerve transectio”
BackgroundNew stereological methods for counting neurons
West, M. J. (1993) · Neurobiology of Aging · doi:10.1016/0197-4580(93)90112-o · Cited by 940 · cited 1×
“We counted the number of TH-IR and Nissl-stained SNpc neurons in seven mice per group, using the optical fractionator metho”
MethodHundhausen, C., Misztela, D., Berkhout, T. A., Broadway, N., Saftig, P., Reiss, K., Hartmann, D., Fahrenholz, F., Postina, R., Matthews, V., et al. (2003) · Blood · doi:10.1182/blood-2002-12-3775 · Cited by 713 · cited 1×
“In support of this concept, we found >300 pg of soluble CX3CL1 per milligram of aqueous extracts of the adult mouse brain (data not shown), and others have reported the presence in the CNS of ADAM10, the catalyst of constitutive CX3CL1 releas”
BackgroundDecreased atherosclerosis in CX3CR1–/– mice reveals a role for fractalkine in atherogenesis
Lesnik, P., Haskell, C. A., & Charo, I. F. (2003) · Journal of Clinical Investigation · doi:10.1172/jci15555 · Cited by 487 · cited 1×
“None of these attributes of altered microglial function are observed in Cx3cr1 −/− mic”
BackgroundWright, G. J., Puklavec, M. J., Willis, A. C., Hoek, R. M., Sedgwick, J. D., Brown, M. H., & Barclay, A. N. (2000) · Immunity · doi:10.1016/s1074-7613(00)00023-6 · Cited by 388 · cited 1×
“Mice deficient for CD200, a neuronal glycoprotein whose receptor, CD200R, is expressed by all myeloid cells, show aberrant microglial physiology including morphological activation of microglia in the resting CNS and accelerated response to facial nerve transectio”
BackgroundExpression of CX 3 CR1 chemokine receptors on neurons and their role in neuronal survival
Meucci, O., Fatatis, A., Simen, A. A., & Miller, R. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.090017497 · Cited by 385
Chapman, G. A., Moores, K., Harrison, D., Campbell, C. A., Stewart, B. R., & Strijbos, P. J. L. M. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-15-j0004.2000 · Cited by 349
Production and neuroprotective functions of fractalkine in the central nervous system
Mizuno, T., Kawanokuchi, J., Numata, K., & Suzumura, A. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02867-1 · Cited by 339 · cited 1×
“; and CX3CL1 suppresses neuronal cell death in LPS- and IFN-γ–stimulated microglial and neuronal coculture”
BackgroundMolecular insights on the cerebral innate immune system
Rivest, S. (2003) · Brain, Behavior, and Immunity · doi:10.1016/s0889-1591(02)00055-7 · Cited by 338
Interleukin-1 and neuronal injury: mechanisms, modification, and therapeutic potential
Rothwell, N. (2003) · Brain, Behavior, and Immunity · doi:10.1016/s0889-1591(02)00098-3 · Cited by 291 · cited 1×
“These findings were noteworthy, because IL-1 action through IL-1 receptor type 1 (IL-1R1) has been consistently associated with neurodegeneration in vivo”
BackgroundMilligan, E. D., Zapata, V., Chacur, M., Schoeniger, D., Biedenkapp, J., O'Connor, K. A., Verge, G. M., Chapman, G., Green, P., Foster, A. C., et al. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03709.x · Cited by 289 · cited 1×
“, and intrathecal injection of CX3CL1 enhances nociceptio”
BackgroundHuang, D., Shi, F., Jung, S., Pien, G. C., Wang, J., Salazar‐Mather, T. P., He, T. T., Weaver, J. T., Ljunggren, H., Biron, C. A., et al. (2006) · The FASEB Journal · doi:10.1096/fj.05-5465com · Cited by 284
Self-citationMcDermott, D. H., Halcox, J. P. J., Schenke, W. H., Waclawiw, M. A., Merrell, M. N., Epstein, N., Quyyumi, A. A., & Murphy, P. M. (2001) · Circulation Research · doi:10.1161/hh1701.095642 · Cited by 256 · cited 1×
“, and an allele of CX3CR1 that exerts impaired adhesive function and blunted signaling is associated with dominantly inherited, reduced risk for atherosclerotic end point”
BackgroundMice deficient in fractalkine are less susceptible to cerebral ischemia-reperfusion injury
Soriano, S. G., Amaravadi, L. S., Wang, Y. F., Zhou, H., Yu, G. X., Tonra, J. R., Fairchild-Huntress, V., Fang, Q., Dunmore, J. H., Huszar, D., et al. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00033-4 · Cited by 222 · cited 1×
“Furthermore, Cx3cl1 −/− mice show relative protection from cerebral ischemi”
BackgroundThe Chemokine Fractalkine Inhibits Fas-Mediated Cell Death of Brain Microglia
Boehme, S. A., Lio, F. M., Maciejewski-Lenoir, D., Bacon, K. B., & Conlon, P. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.1.397 · Cited by 192 · cited 1×
“In vitro , CX3CL1 promotes neuronal survival and inhibits microglial apoptosi”
BackgroundMilligan, E., Zapata, V., Schoeniger, D., Chacur, M., Green, P., Poole, S., Martin, D., Maier, S. F., & Watkins, L. R. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04470.x · Cited by 178
Targeted deletion of CX3CR1 reveals a role for fractalkine in cardiac allograft rejection
Haskell, C. A., Hancock, W. W., Salant, D. J., Gao, W., Csizmadia, V., Peters, W., Faia, K., Fituri, O., Rottman, J. B., & Charo, I. F. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12976 · Cited by 167 · cited 1×
“CX3CR1 is responsible for recruiting natural killer cells to cardiac allograft”
BackgroundSugama, S., Yang, L., Cho, B. P., DeGiorgio, L. A., Lorenzl, S., Albers, D. S., Beal, M. F., Volpe, B. T., & Joh, T. H. (2003) · Brain Research · doi:10.1016/s0006-8993(02)04085-4 · Cited by 164 · cited 1×
“We counted the number of TH-IR and Nissl-stained SNpc neurons in seven mice per group, using the optical fractionator metho”
MethodGeneration and Analysis of Mice Lacking the Chemokine Fractalkine
Cook, D. N., Chen, S., Sullivan, L. M., Manfra, D. J., Wiekowski, M., Prosser, D. M., Vassileva, G., & Lira, S. A. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.9.3159-3165.2001 · Cited by 157 · cited 1×
“Fractalkine (CX3CL1), the exclusive ligand for CX3CR1, is synthesized as a transmembrane glycoprotein, from which a soluble chemokine can be proteolytically release”
BackgroundSelf-citationCarson, M. J., Reilly, C. R., Sutcliffe, J. G., & Lo, D. D. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65294-7 · Cited by 98
Facchinetti, F., Sasaki, M., Cutting, F. B., Macdonald, J. E., Reif, D. W., Beal, M. F., Huang, P. L., Dawson, T. M., Gurney, M. E., Dawson, V. L., et al. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00492-8 · Cited by 98
Hulshof, S. C. J., van Haastert, E. S., Kuipers, H. F., van den Elsen, P. J., Groot, C. J. A. D., van der Valk, P., Ravid, R., & Biber, K. P. H. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.9.899 · Cited by 93
Nataf, S., Anginot, A., Vuaillat, C., Malaval, L., Fodil, N., Chereul, E., Langlois, J., Dumontel, C., Cavillon, G., Confavreux, C., et al. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62251-1 · Cited by 79 · cited 1×
“Altered microglial function can cause CNS disease in humans: homozygous deficiency of either type 2 triggering receptor expressed on myeloid cells ( TREM2 ) or its intracellular adaptor TYROBP causes adult onset dementing leukoencephalopathy, which is recapitulated in Tyrobp −/− mic”
BackgroundKüst, B., Brouwer, N., Mantingh-Otter, I., Boddeke, H. W. G. M., & Copray, J. C. V. M. (2003) · Amyotrophic Lateral Sclerosis · doi:10.1080/14660820301185 · Cited by 41 · cited 1×
“Notably, there is precedent for a gender effect in this model, as absence of the p75 NTR receptor was selectively beneficial for female, but not male, SOD1 G93A mic”
BackgroundThe fractalkine receptor CX3CR1 is a key mediator of atherogenesis
Cybulsky, M. I., & Hegele, R. A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18237 · Cited by 40 · cited 1×
“Recent evidence from animal models implicates CX3CL1 as a mediator of atherosclerosi”
BackgroundEffects of cardiotrophin‐1 (CT‐1) in a mouse motor neuron disease
Mitsumoto, H., Klinkosz, B., Pioro, E. P., Tsuzaka, K., Ishiyama, T., O'Leary, R. M., & Pennica, D. (2001) · Muscle & Nerve · doi:10.1002/mus.1068 · Cited by 32 · cited 1×
“Limb strength was assessed between the ages of 7 and 23 weeks ( n = 6–20 per group) as describe”
MethodSelf-citationKüst, B., Brouwer, N., Mantingh-Otter, I., Boddeke, H. W. G. M., & Copray, J. C. V. M. (2003) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/14660820310012745 · Cited by 28
(2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.26.15393-h · Cited by 3
Zujovic (2000) · doi:10.1002/(sici)1098-1136(20000215)29:4
Cited by
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., Ransohoff, R. M., Greenberg, M. E., Barres, B. A., & Stevens, B. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.026 · Cited by 4,089
“Microglia were labeled using the CX3CR1+/GFP mouse line in which all microglia express EGFP under the control of fractalkine receptor, CX3CR1, expression (Figure 1 and see Figures S1 and S5 available online; Cardona et al., 2006; Jung et al., 2000; Saederup et al., 2010).”
Self-citationSynaptic Pruning by Microglia Is Necessary for Normal Brain Development
Paolicelli, R. C., Bolasco, G., Pagani, F., Maggi, L., Scianni, M., Panzanelli, P., Giustetto, M., Ferreira, T. A., Guiducci, E., Dumas, L., et al. (2011) · Science · doi:10.1126/science.1202529 · Cited by 4,244
Microglia: Active sensor and versatile effector cells in the normal and pathologic brain
Hanisch, U.-K., & Kettenmann, H. (2007) · Nature Neuroscience · doi:10.1038/nn1997 · Cited by 3,676
Mechanisms underlying inflammation in neurodegeneration
Glass, C. K., Saijo, K., Winner, B., Marchetto, M. C., & Gage, F. H. (2010) · Cell · doi:10.1016/j.cell.2010.02.016 · Cited by 3,580
“The chemokine receptor CX3CR1 is present on microglia, and CX3CR1 knockout mice show increased toxicity in response to systemic LPS treatment and augmented neurodegeneration in the substantia nigra following MPTP administration (Cardona et al., 2006).”
Kettenmann, H., Hanisch, U.-K., Noda, M., & Verkhratsky, A. (2011) · Physiological Reviews · doi:10.1152/physrev.00011.2010 · Cited by 3,547
Metadata
- Authors
- Cardona, A. E., Pioro, E. P., Sasse, M. E., Kostenko, V., Cardona, S. M., Dijkstra, I. M., Huang, D., Kidd, G., Dombrowski, S., Dutta, R., Lee, J.-C., Cook, D. N., Jung, S., Lira, S. A., Littman, D. R., & Ransohoff, R. M.
- Affiliations
- Cleveland Clinic (US)
- National Institute of Environmental Health Sciences (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Ransohoff, Richard M
- ORCID
- Venue
- Nature Neuroscience
- Published
- 2006-06-18
- Volume
- 9
- Issue
- 7
- Pages
- 917-924
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- OpenAlex
- W2113107925
- Cited by
- 1,531
- References
- 39
- Citations by year
- 2026: 46 · 2025: 44 · 2024: 84 · 2023: 62 · 2022: 83 · 2021: 73 · 2020: 66 · 2019: 76 · 2018: 95 · 2017: 90 · 2016: 87 · 2015: 102 · 2014: 133 · 2013: 104 · 2012: 90
- FWCI
- 32.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (NS32151, R01NS032151)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- microglia, CX3CR1, microglial neurotoxicity, neuroinflammation, lipopolysaccharide, Parkinson's disease, amyotrophic lateral sclerosis, neuronal loss, CX3CR1 knockout mice
- MeSH terms
- CX3C Chemokine Receptor 1, Analysis of Variance, Animals, Calcium-Binding Proteins, Cells, Cultured, Central Nervous System, Disease Models, Animal, Flow Cytometry, Immunohistochemistry, Lipopolysaccharides, Mice, Inbred C57BL, Mice, Transgenic, Microfilament Proteins, Nerve Tissue Proteins, Neurons, Parkinson Disease, Cytokines, Motor Neuron Disease, Cell Death, Microglia, Receptors, Chemokine, Neurotoxicity Syndromes, Green Fluorescent Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.